The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 19, 2018
Filed:
Jul. 07, 2017
Applicant:
Bristol-myers Squibb Company, Princeton, NJ (US);
Inventors:
Michael J. Orwat, New Hope, PA (US);
Donald J. P. Pinto, Churchville, PA (US);
Leon M. Smith, II, Somerset, NJ (US);
James R. Corte, Yardley, PA (US);
Shefali Srivastava, Jaipur, IN;
Assignee:
Bristol-Myers Squibb Company, Princeton, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); C07D 471/04 (2006.01); C07D 401/10 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01); C07D 217/26 (2006.01); C07D 401/12 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
C07D 401/10 (2013.01); C07D 217/26 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 413/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract
The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.